A new study published in Aging Cell demonstrates that artificial intelligence can be used not just to accelerate drug discovery, but to fundamentally transform how it’s done—by targeting the full complexity of biological aging.
Systems-level drug design could point the way to more effective therapies for aging and chronic disease
